Patterns of cardiovascular diseases in COVID-19 patients admitted to tertiary cardiac care centre

Beeresha Puttegowda1, Arun B Shivashankarappa1, Suvradip Dutta1

  • 1Department of Cardiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bangalore, Karnataka, India.

Indian Heart Journal
|October 25, 2021
PubMed

Insights

The most frequent cardiovascular disease in COVID-19 patients was acute coronary syndrome (ACS), particularly ST-segment elevation myocardial infarction (STEMI). Advanced age and specific biomarkers predict higher mortality risk in these patients.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • COVID-19 can significantly impact cardiovascular health.
  • Understanding cardiovascular disease (CVD) patterns in COVID-19 patients is crucial for management.
  • Tertiary cardiac care centers play a vital role in treating complex cardiovascular cases.

Purpose of the Study:

  • To analyze the spectrum of cardiovascular diseases (CVDs) in patients with COVID-19.
  • To identify risk factors associated with mortality in COVID-19 patients with CVDs.

Main Methods:

  • Retrospective analysis of 511 adult COVID-19 patients with new or pre-existing CVDs.
  • Inclusion of data on clinical features, ECG, echocardiography, biomarkers, and laboratory parameters.
  • Analysis of in-hospital mortality and associated clinical factors.

Main Results:

  • Acute coronary syndrome (ACS) was the most common CVD (50.7%), with ST-segment elevation myocardial infarction (STEMI) being more frequent than non-ST-segment elevation ACS (NSTE-ACS).
  • Possible myocarditis (10.1%) and rhythm/conduction abnormalities (28.2%) were also observed.
  • In-hospital mortality was 18.9%, associated with older age, elevated serum ferritin, D-dimer, NT-pro-BNP, leukocytosis, lymphopenia, lower hemoglobin, pre-existing CVDs, heart failure, cardiogenic shock, atrial fibrillation, and renal failure.

Conclusions:

  • Acute coronary syndrome (ACS) is the predominant cardiovascular disease manifestation in COVID-19 patients.
  • Several clinical and laboratory markers, including advanced age, elevated inflammatory markers, and pre-existing cardiovascular conditions, are significantly associated with increased mortality.
  • Early identification and management of these risk factors are essential for improving outcomes in COVID-19 patients with cardiovascular complications.
Abstract

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
71
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
48
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
94
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
81
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
120
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
79